样式: 排序: IF: - GO 导出 标记为已读
-
Surrogate Endpoints in APOL1-Associated Kidney Disease: Evaluation in Three Cohorts Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-11-05 Alix Rosenberg, Carina Flaherty, Amanda Anderson, Lawrence J Appel, Josef Coresh, Jiang He, Jim Lash, Celina Liu, Panduranga Rao, Jonathan Taliercio, Aditya Surapaneni, Morgan Grams, on behalf of the CRIC Study Investigators
lysis included African-American participants in the Atherosclerosis Risk in Communities (ARIC) study (N=3071), the Chronic Renal Insufficiency Cohort (CRIC; N=998), and the African American Study of Kidney Disease and Hypertension (AASK; N=609). Surrogate endpoints included three-year 30% and 40% decline in glomerular filtration rate (GFR), doubling of urine protein-to-creatinine ratio (UPCR), and
-
Bisphosphonate Use After Kidney Transplantation Is Associated with Lower Fracture Risk Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-11-05 Joseph M Kahwaji, Su-Jau Yang, John Sim, Chong Young Parke, Roland L. Lee
bisphosphonates associates with lower incidence of non-vertebral fractures after kidney transplantation. Methods: We conducted a retrospective review for all Southern California Kaiser Permanente kidney transplant recipients with osteoporosis transplanted between 2000 and 2019. Baseline variables were collected. Those prescribed an oral bisphosphonate were compared to those who were not. The primary
-
Cardiopulmonary Exercise Testing in Patients with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-11-01 Marcelle Tuttle, Mark J. Sarnak
An abstract is unavailable.
-
Cancer Screening among Patients with Kidney Failure Requiring Hemodialysis: Where We Are and Where We Are Going Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-11-01 Deepa Jayaram, Ladan Golestaneh
An abstract is unavailable.
-
Impaired Incretin Homeostasis in Nondiabetic Moderate-to-Severe CKD Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-11-01 Armin Ahmadi, Jorge Gamboa, Jennifer E. Norman, Bamba Enkhmaa, Madelynn Tucker, Brian J. Bennett, Leila R. Zelnick, Sili Fan, Lars F. Berglund, Talat Alp Ikizler, Ian H. de Boer, Bethany P. Cummings, Baback Roshanravan
with insulin response and coincided with persistently greater glucagon levels to oral glucose tolerance testing in CKD.Disruption in the incretin system and glucagon dynamics may contribute to metabolic complications in moderate-to-severe CKD. Background Incretins are regulators of insulin secretion and glucose homeostasis metabolized by dipeptidyl peptidase-4 (DPP-4). CKD may modify incretin release
-
Classification of Predictors of Rapid Development of Kidney Failure and Short-Term Changes in Concentration of Circulating Proteins Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-31 Hiroki Kobayashi, Helen C. Looker, Katsuhito Ihara, Zaipul I. Md Dom, Eiichiro Satake, Sok Cin Tye, Kevin L. Duffin, Alessandro Doria, Robert G. Nelson, Andrzej S. Krolewski
ere measured by OLINK proteomics platform at baseline and after a median interval of 3-4 years in 106 individuals with type 1 and 77 with type 2 diabetes in two case-control studies. During 10-year follow-up, 31 and 26 individuals, respectively, developed rapid KF. RESULTS: Deltas for 40 proteins predicted rapid KF in both studies. All were better predictors than delta urine albumin-creatinine ratio
-
Neighborhood Socioeconomic Deprivation is Associated with Worse Outcomes in Pediatric Kidney Transplant Recipients Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-31 Chloe E. Douglas, Miranda C. Bradford, Rachel M Engen, Yue-Harn Ng, Aaron Wightman, Reya Mokiao, Sharon Bartosh, André A S Dick, Jodi M. Smith
listing transplanted January 1st, 2010, to May 31st, 2022 (N=9,178) were included from the Scientific Registry of Transplant Recipients. Recipients were stratified into three groups according to Material Community Deprivation Index score, with greater score representing higher neighborhood socioeconomic deprivation. Outcomes were modeled using multivariable logistic regression and Cox proportional
-
Proteomic Analysis Uncovers Multi-Protein Signatures Associated with Early Diabetic Kidney Disease in Youth with Type 2 Diabetes Mellitus Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-21 Laura Pyle, Ye Ji Choi, Phoom Narongkiatikhun, Kumar Sharma, Sushrut Waikar, Anita Layton, Kalie L Tommerdahl, Ian de Boer, Timothy Vigers, Robert G. Nelson, Jane Lynch, Frank III Brosius, Pierre J. Saulnier, Jesse A. Goodrich, Jeanie B. Tryggestad, Elvira Isganaitis, Fida Bacha, Kristen J. Nadeau, Daniel van Raalte, Matthias Kretzler, Hiddo Heerspink, Petter Bjornstad
in-depth analysis of 6596 proteins (SomaScan 7K) in 374 baseline plasma samples from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study to identify multi-protein signatures associated with the onset of albuminuria (urine albumin-to-creatinine ratio [UACR] ≥30 mg/g), a rapid decline in estimated glomerular filtration rate (eGFR) [annual eGFR decline >3 mL/min/1.73m2 and/or
-
Risk of Surgical Site Infections after Tooth Extraction in Chronic Kidney Disease: A Retrospective Real-World Study in Japan Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-23 Miho Ishimaru, Sachiko Ono, Masao Iwagami, Yoshihisa Miyamoto, Risako Mikami, Jun Aida
An abstract is unavailable. This article is available as a PDF only.
-
Reliability of Glomerular Filtration Rate Estimated by Creatinine-Based Formulas in Moderate to Severe Proteinuria Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-24 Carmine Zoccali, Fabio Pasquale Provenzano, Giovanni Tripepi, Fabiola Carrara, Francesca Mallamaci, Annalisa Perna, Pierre Delanaye, Pietro Ruggenenti, Giuseppe Remuzzi
on. Methods: We utilized data from the Ramipril in non-diabetic renal failure (REIN 1) and REIN 2 trials involving non-diabetic chronic kidney disease (CKD) patients with proteinuria to compare eGFRs derived from the CKD Epidemiology Consortium (CKD-EPI)formulas (with and without race), and the European Kidney Function Consortium (EKFC) equations with iohexol clearance (a gold-standard GFR measure
-
Albuminuria and Rapid Kidney Function Decline as Selection Criteria for Kidney Clinical Trials in Type 1 Diabetes Mellitus Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-18 Youngshin Keum, Maria Luiza Caramori, David Z. Cherney, Jill P. Crandall, Ian H. de Boer, Ildiko Lingvay, Janet B. McGill, Sarit Polsky, Rodica Pop-Busui, Peter Rossing, Ronald J. Sigal, Michael Mauer, Alessandro Doria
Background: The optimal criteria to select individuals with type 1 diabetes mellitus (T1D) and albuminuric or normoalbuminuric diabetic kidney disease (DKD), who are at risk of rapid kidney function decline, for clinical trials are unclear. Methods: This study analyzed data from the Preventing Early Renal Loss in Diabetes (PERL) clinical trial, which investigated whether allopurinol slowed kidney function
-
Impairment of Cardiovascular Functional Capacity in Mild to Moderate Kidney Dysfunction Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-14 Kenneth Lim, Matthew Nayor, Eliott Arroyo, Heather N. Burney, Xiaochun Li, Yang Li, Ravi Shah, Joseph Campain, Douglas Wan, Stephen Ting, Thomas F. Hiemstra, Ravi Thadhani, Sharon Moe, Daniel Zehnder, Martin G. Larson, Ramachandran S. Vasan, Gregory D. Lewis
ascular functional capacity can detect abnormalities in mild-to-moderate CKD. Methods: In a cross-sectional study, we examined 3,075 participants from the Framingham Heart Study (FHS) and 451 participants from the Massachusetts General Hospital Exercise Study (MGH-ExS) who underwent cardiopulmonary exercise testing (CPET). Participants were stratified by estimated glomerular filtration rate (eGFR):
-
Challenges and Opportunities in Advanced Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-15 Steven Fishbane, Candice Halinski, Alla Alaiev, Ellen Porzelt, Vipul Sakhiya, Noreen McGroarty
An abstract is unavailable. This article is available as a PDF only.
-
Perspectives on Long-Term Follow-Up Among Living Kidney Donors Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-15 Sunita K. Singh, Allison Jaure, Natasha Caton, Olwyn Johnson, Camilla S. Hanson, Amanda Dominello, Maia P. Gill, Linnea Young, Kathy Yetzer, Sarah Chritchley, Doris Chang, John S. Gill
semi-structured interviews with 12 living kidney donors. The survey was developed based on themes identified in the semi-structured interviews, guidance from the research and clinical teams, and feedback from pilot testing with six previous donors. Results: Most (73%) respondents received follow-up after the first donation year from a primary care provider, and 70% reported annual follow-up visits
-
Sudden Cardiac Death Reporting in US Dialysis Patients: Comparison of USRDS and National Death Index Data Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-15 Yoshitsugu Obi, Anna Xu, Jonathan A. Wilson, Patti L. Ephraim, Daniel E. Weiner, Julia J. Scialla, Bernard G. Jaar, L. Ebony Boulware, Benjamin Goldstein, Tariq Shafi
h Index (NDI) is the epidemiological standard for assessing causes of death for the United States population. The cause of death has not been compared between the USRDS and the NDI. Methods: Among 39,507 adults starting dialysis in the US, we identified 6436 patients who died between 2003-2009. We classified the cause of death as SCD, non-SCD CVD, cancer, infection, and others; and compared the USRDS
-
Early Effects of the End-Stage Renal Disease Treatment Choices Model on Kidney Transplant Waitlist Additions Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-16 Vishnu S. Potluri, Yuvaram N.V. Reddy, Sri Lekha Tummalapalli, Chen Peng, Qian Huang, Yueming Zhao, Genevieve P. Kanter, Jingsan Zhu, Joshua M. Liao, Amol Navathe
odel in 2021, the largest mandatory trial of payment incentives in kidney disease, which randomized 30% of healthcare markets to financial bonuses/penalties to improve kidney transplantation and home dialysis use. This study examines the effect of ETC payment adjustments on US kidney transplant waitlist additions. Methods: Using data from the Organ Procurement and Transplantation Network registry,
-
African American Patients’ Perspectives on Determinants of Hemodialysis Adherence and Use of Motivational Interviewing to Improve Hemodialysis Adherence Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-16 Kemberlee Bonnet, Erin M. Bergner, Melissa Ma, Kathryn Taylor, Emily Desantis, Maria A. Pena, Queen Henry-Okafor, Toddra Liddell, Devika Nair, Rachel Fissell, Juliet Iwelunmor, Collins Airhihenbuwa, Joseph Merighi, Kenneth Resnicow, Ruth Q. Wolever, Kerri L. Cavanaugh, David Schlundt, Ebele M. Umeukeje
it. We assessed perspectives of AA hemodialysis patients on unique factors impacting dialysis adherence, and use of motivational interviewing, an evidence-based intervention, to improve these factors, dialysis adherence, and outcomes in AAs. Methods: Self-identified AA hemodialysis patients (N=22) watched a brief video describing motivational interviewing and then completed a semi-structured interview
-
Baseline, Early Changes, and Residual Albuminuria: Post-hoc Analysis of a Clinical Trial of Dapagliflozin in Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-17 Dominique van Mil, Priya Vart, Glenn M. Chertow, Ron T. Gansevoort, Peter Rossing, Robert D. Toto, Ricardo Correa-Rotter, Anna Maria Langkilde, C. David Sjöström, David C. Wheeler, Hiddo J.L. Heerspink
n patients with CKD and albuminuria, with and without type 2 diabetes. Methods: In this post-hoc analysis of the DAPA-CKD trial, 4304 adult patients with CKD were randomized to dapagliflozin 10mg or placebo as adjunct to maximally tolerated renin-angiotensin-system (RAAS) inhibitors. The primary endpoint was a composite of sustained ≥50% decline in estimated glomerular filtration rate, kidney failure
-
Meat Your Veggies: Could Plant-Based Meat Alternatives Help Improve Outcomes in Chronic Kidney Disease and Urinary Stone Disease? Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-15 Annabel Biruete, Nooshan Mirmohammadali
An abstract is unavailable.
-
Exploring the Challenges and Limitations in Participation of Women Nephrologists at Conferences: A Pilot Study Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-07 Priti Meena, Denisse Arellano-Mendez, Viviane Calice-Silva, Sibel Gokcay Bek, Isabelle Dominique Tomacruz Amante, Manjusha Yadla, Krithika Mohan, Divya Bajpai, Mythri Shankar, Anuja Java, Kalida Soki, Fernanda Arce-Amare, Valerie Luyckx, Sabine Karam
An abstract is unavailable. This article is available as a PDF only.
-
Incorporation of Calcimimetics into ESRD Bundle: Changes in Etelcalcetide Utilization and PTH Control Following End of TDAPA Designation Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-08 Angelo Karaboyas, Junhui Zhao, Junjie Ma, Carol Moore, Najma Saleem, Kevin J. Martin, Stuart M. Sprague, Caroline Smerdon, Roberto Pecoits-Filho, Ronald L Pisoni
n payment adjustment (TDAPA) to an increased bundled payment, with $10.09 per session added for all hemodialysis patients to cover the expense for calcimimetics, whether or not patients are administered etelcalcetide. We leveraged this natural experiment to investigate the impact of this policy change. Methods: This analysis included 713 US in-center hemodialysis patients enrolled in the United States
-
Kidney Outcomes with GLP-1RAs, SGLT2 Inhibitors, DPP-4 Inhibitors, and Sulfonylureas in Type 2 Diabetes and Moderate Cardiovascular Risk Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-08 Joshua J. Neumiller, Jeph Herrin, Kavya Sindhu Swarna, Eric C. Polley, Rodolfo J. Galindo, Guillermo E. Umpierrez, Yihong Deng, Joseph S. Ross, Mindy M. Mickelson, Rozalina G. McCoy
ly initiation of these agents relative to other commonly prescribed glucose-lowering agents in patients at lower baseline cardiovascular disease (CVD) risk remains less clear. Methods: This retrospective observational study emulated an idealized target trial using claims data from OptumLabs® Data Warehouse to test the comparative association of treatment with a dipeptidyl peptidase-4 (DPP-4) inhibitor
-
The Impact of Glucagon-like Peptide-1 Receptor Agonists on Kidney Outcomes: A Meta-Analysis of Randomized Placebo-Controlled Trials Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-08 Luís Mendonça, Henrique Moura, Paulo Castro Chaves, João Sérgio Neves, João Pedro Ferreira
ferent populations. Methods: We conducted a meta-analysis of randomized controlled trials that tested GLP-1 RA treatment vs. placebo in individuals with type 2 diabetes (T2D) or with overweight/obesity status, with or without CKD, with kidney events reported as primary or secondary endpoints. The primary outcome was the occurrence of worsening kidney function, defined as either a doubling of serum
-
Fat Distribution and Urolithiasis Risk Parameters in Uric Acid Stone Formers and Patients with Type 2 Diabetes Mellitus Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-08 Alireza Zomorodian, Xilong Li, John Poindexter, Naim M. Maalouf, Khashayar Sakhaee, Orson W. Moe
ersus external (e.g., dietary) factors to UA stone propensity is challenging due to uncontrolled diets in outpatients in previously published studies. Methods: This compilation of metabolic studies with body composition examined by dual-energy X-ray absorptiometry (DXA) scan, and blood and urine biochemistry collected under a controlled metabolic diet was conducted across three distinct populations:
-
Breast and Prostate Cancer Screening by Life Expectancy in Patients with Kidney Failure on Dialysis Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-09 Michelle Tran, Chun Anna Xu, Jonathan Wilson, Rasheeda Hall, Patti L. Ephraim, Tariq Shafi, Daniel E Weiner, Benjamin A. Goldstein, Julia J. Scialla, on behalf of the Comparative Effectiveness Studies in Dialysis Patients Group
r survival probability. Methods: We conducted a retrospective cohort study using a nationally representative population of HD patients. Patients receiving HD each calendar year from 2003-2018, ≥1 year of Medicare as the Primary Payer, and age 50-69 years were included. The cohort was split into prognosis and cancer screening sets. Models of five-year survival were built in the prognosis set using logistic
-
Prevalence and Outcomes of Chronic Kidney Disease Associated Pruritus: International Results from PDOPPS Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-11 Karthik K. Tennankore, Keith P. McCullough, Brian Bieber, Yeoungjee Cho, David W Johnson, Talerngsak Kanjanabuch, Hideki Kawanishi, Yong-Lim Kim, Mark Lambie, Claudio Rigatto, Jenny Shen, Martin Schreiber, Jeffrey Perl, Ronald L. Pisoni
ransfer to HD. Methods: We analyzed a multicenter, international cohort of PD patients enrolled in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS) from 2014-2022. Pruritus was assessed at entry into PDOPPS with a single-question Likert Scale capturing the extent to which patients were bothered by itch ranging from 1: Not at all, to 5: Extremely. The KDQOL-36 and the Centre for
-
Incidence and Proportion of Primary Focal Segmental Glomerulosclerosis (FSGS) among a Racially and Ethnically Diverse Adult Patient Population between 2010-2021 Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-11 Mercedes A Munis, Qiaoling Chen, T Matthew Hill, Min Zhuo, Asher D. Schachter, Simran K. Bhandari, Aviv Hever, Teresa N Harrison, Ancilla W Fernandes, John J. Sim
large diverse patient population in the United States. Methods: A cross-sectional study (2010-2021) was performed within an integrated health system in patients (age ≥18yrs) with biopsy-proven FSGS. Among biopsies with FSGS as the first diagnosis on pathology report, chart reviews were performed to determine primary FSGS, defined as podocyte foot process effacement ≥80% on electron microscopy. The
-
Benefits and Harms of Coronary Revascularization in Non-Dialysis-Dependent CKD and Ischemic Heart Disease: A Systematic Review and Meta-Analysis Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-04 Dipal M. Patel, Lisa M. Wilson, Renee F. Wilson, Xuhao Yang, Troy Gharibani, Karen A. Robinson
tweigh benefits of revascularization. Evidence on the balance of these risks and benefits, specifically in people with non-dialysis-dependent CKD, is lacking. Methods: We conducted a systematic review of randomized controlled trials (RCTs) to assess the risks and benefits of revascularization, compared to medical management, among adults or children with ischemic heart disease and CKD not requiring
-
Gender Equity in Academic Nephrology: Enough Talk, Now Is the Time to Act Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-04 Liz Lightstone
An abstract is unavailable.
-
The Role of Repeat Kidney Biopsies in Lupus Nephritis in a Largely Black and Hispanic Population Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-30 Anitha Ramu, Rosalba Santana de Roberts, Nang San Hti Lar Seng, Gopisree Peringeth, Hana Rajevac, James M. Pullman, Meryl Waldman, Ladan Golestaneh, Belinda Jim
An abstract is unavailable. This article is available as a PDF only.
-
Diurnal and Daily Symptom Variation in Patients with ESKD. Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-10-01 Dawn P Edwards
-
Plasma Biomarkers of Kidney Health and Mortality in Diabetes and Chronic Kidney Disease in the REGARDS Study. Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-20 Teresa K. Chen, Michelle M. Estrella, Ronit Katz, Mark J. Sarnak, Morgan E. Grams, Mary Cushman, Emily B. Levitan, Chirag R. Parikh, Paul L. Kimmel, Joseph V. Bonventre, Steven G. Coca, Orlando M. Gutiérrez, Joachim H. Ix, Michael G. Shlipak
eatinine-based eGFR (eGFRcr) <60 ml/min/1.73m2 from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study, Cox proportional hazards regression was used to determine hazard ratios of mortality by plasma concentrations of soluble tumor necrosis factor receptors 1 and 2 (TNFR1, TNFR2), soluble urokinase-type plasminogen activator receptor (suPAR), kidney injury molecule 1
-
Cost-effectiveness of empagliflozin in chronic kidney disease with or without albuminuria Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-20 Motoki Odawara, Hiroshi Nishi, Satoshi Kodera, Masahide Kondo, Masaomi Nangaku
inine ratio (UACR). This enables the cost-effectiveness analysis of empagliflozin in subgroups stratified by these two parameters. Methods: A cost-utility analysis using the Markov model was performed to evaluate the cost-effectiveness of adding empagliflozin to the standard treatment for CKD in Japan over 20 years of observation. Each cohort with the initial eGFR (≥45 but <60 ml/min per 1.73 m2, ≥30
-
Living Donation and Pregnancy-Related Complications: State of the Evidence and Call To Action for Improved Risk Assessment Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-20 Ana P. Rossi, Goni Katz-Greenberg, Lisa Coscia, Carla W. Brady, Christina Doligalski, Roxanna A. Irani, Arthur Matas, Silvi Shah, Krista L. Lentine, Contraception and Pregnancy after Transplantation and Living Donation Controversies Conference Participants On behalf of the AST WHCOP Reproductive Health
he effect of donation on future pregnancies and of pregnancy-related complications on postdonation outcomes. In February 2023, the American Society of Transplantation Women's Health Community of Practice held a virtual Controversies Conference on reproductive health, contraception, and pregnancy after transplantation and living donation. Experts in the field presented the available data. Smaller breakout
-
Medication Burden and Adverse Cardiovascular Events and Death in Patients Treated with Maintenance Hemodialysis: A Nationwide Cohort Study Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-20 Cheol Ho Park, Ye Eun Ko, Ga Young Heo, Bo Yeon Kim, Seong Ju Oh, So Young Han, Jung Tak Park, Seung Hyeok Han, Tae-Hyun Yoo, Shin-Wook Kang, Hyung Woo Kim
ied to investigate the prognostic implications of medication burden regarding adverse outcomes in patients with end-stage kidney disease with maintenance hemodialysis. Methods We analyzed 26,690 patients receiving maintenance hemodialysis who participated in the Periodic Hemodialysis Quality Assessment conducted by the Health Insurance Review and Assessment Service. The exposure of interest was the
-
Utility of Genetic Testing in Adults with Chronic Kidney Disease: A Systematic Review and Meta-Analysis Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-19 Clara Schott, Victoria Lebedeva, Cambrie Taylor, Saeed Abumelha, Pavel S. Roshanov, Dervla M. Connaughton
f this study is to estimate the diagnostic yield of genetic testing in adults with CKD. Methods: Cohort studies that report diagnostic yield of genetic testing in adults with CKD published in PubMed or Embase between January 1, 2005, and December 31, 2023, were included. The Joanna Briggs Institute critical appraisal tool for prevalence studies was used to assess bias. Duplicate independent data extraction
-
SGLT2 inhibitors and kidney outcomes across the spectrum of kidney disease: a systematic review and meta-analysis Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-16 Bernardo F. Spiazzi, Giovana F. Piccoli, Laura F. Wayerbacher, João Pedro N. Lubianca, Bruno G. Scalco, Mariana H. Scheffler, Bruna L. Fraga, Verônica Colpani, Fernando Gerchman
aim to evaluate the effect of SGLT2 inhibitors on kidney outcomes across the Kidney Disease: Improving Global Outcomes (KDIGO) classification and urinary albumin-to-creatinine ratio (UACR) levels. Methods: We have searched MEDLINE (PubMed), EMBASE and the Cochrane Central Register of Controlled Trials from inception up to August 8th, 2023. In pairs, researchers selected large (≥500 subjects per arm)
-
Phenotypes of Dialysis-Requiring Acute Kidney Injury and Associations with Mortality in a South American Population Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-12 Conrado Lysandro R. Gomes, Thais Lyra Cleto-Yamane, Patricia da Silva Fucuta, Heitor Blesa Farias, Frederico Ruzany, José Hermógenes Rocco Suassuna
inical characteristics and mortality risks.The study underscores the necessity of age-specific AKI management strategies, informed by diverse etiologies and survival outcomes across the lifespan. Background AKI is a complex syndrome typically classified into strict categories. Alternatively, it may be more accurate to consider it as an intermediate event between an initiating cause and its outcome
-
Bioimpedance-Guided Fluid Removal in Continuous Kidney Replacement Therapy: The VENUS Randomized Clinical Trial Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-12 Jung Nam An, Hyung Jung Oh, Sohee Oh, Harin Rhee, Eun Young Seong, Seon Ha Baek, Shin Young Ahn, Jang-Hee Cho, Jung Pyo Lee, Dong Ki Kim, Dong-Ryeol Ryu, Soyeon Ahn, Sejoong Kim
nagement for achieving estimated euvolemia (e-euvolemia) in CKRT-treated patients. Methods: In a multi-center randomized controlled trial from July 2017 to July 2020, the patients with AKI requiring CKRT were eligible if the weight at the start of CKRT had increased by ≥5% compared to the weight at the time of admission, or total body water (TBW)/ height (H)2 ≥13 L/m2. We randomly assigned 208 patients
-
Association of Neighborhood Social Determinants of Health with Acute Kidney Injury during Hospitalization Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-11 Lama Ghazi, Vibhu Parcha, Tomonori Takeuchi, Catherine R. Butler, Elizabeth Baker, Gabriela R. Oates, Lucia D. Juarez, Ariann F. Nassel, AKM Fazlur Rahman, Edward D. Siew, Xinyuan Chen, Orlando M. Gutierrez, Javier A. Neyra
a Deprivation Index) had a 10% greater odds of developing AKI than counterparts in the lowest Area Deprivation Index tertile. Patients who lived in rural areas had 25% greater odds of not recovering from AKI by hospital discharge.This study demonstrates an association between neighborhood disadvantage and rurality on the development of AKI and lack of recovery from AKI. Further work is needed to understand
-
Associations of Abnormal Fluid Status, Plasma Sodium Disorders, and Low Dialysate Sodium with Mortality in Patients on Hemodialysis Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-10 Jule Pinter, Bernard Canaud, Kaitlin J. Mayne, Stefano Stuard, Ulrich Moissl, Jeroen Kooman, Kitty J. Jager, Nicholas C. Chesnaye, Brendan Smyth, Bernd Genser
ree of fluid overload, 28% in severe fluid overload, and 4% in fluid depletion; 11% were spent in hyponatremia and 1% in hypernatremia; and 64% were spent on low dialysate sodium.Cumulative exposure to even mild fluid overload was associated with higher risk of death, and this association was independent of abnormal plasma sodium and low dialysate sodium. Background Abnormal fluid and plasma sodium
-
Symptom Burden and Altered Mineral Metabolism in Advanced Chronic Kidney Disease: Two Peas in a Pod Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-10 Orlando M. Gutiérrez
An abstract is unavailable.
-
Experiences of Social Isolation and Loneliness in Chronic Kidney Disease: A Secondary Qualitative Analysis Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-09 Amanda Sluiter, Rosanna Cazzolli, Allison Jaure, Nicole Scholes-Robertson, Jonathan C. Craig, David W. Johnson, Andrea Matus Gonzalez, Benedicte Sautenet, Ben J. Smith, Karine Manera, for the SONG initiative
nts and caregivers. Background Many patients with CKD experience loneliness and social isolation, which are associated with a higher risk of mortality, morbidity, and poor mental health. We aimed to describe the perspectives of patients with CKD and their caregivers on loneliness and social isolation, to inform strategies to increase social participation. Methods A secondary analysis of qualitative
-
Comparative Effectiveness of Bisoprolol, Carvedilol, and Metoprolol Succinate in Patients with Heart Failure and Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-06 Cheng-Wei Huang, Albert S. Yu, Hui Zhou, Katherine Pak, Sally F. Shaw, Jiaxiao Shi, Benjamin I. Broder, John J. Sim
An abstract is unavailable. This article is available as a PDF only.
-
Intradialytic Hypotension in the Face of Using Different Antihypertensive Medication Classes Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-09-04 Csaba P. Kovesdy
An abstract is unavailable.
-
Where Are Patients' Voices in Chronic Kidney Disease? Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-30 Despina Rüssmann, Prabir Roy-Chaudhury, Glenn M. Chertow, Patrick Gee, Cynthia Chauhan, Steven Macari, Michael Murphy, Patrick Rossignol
An abstract is unavailable.
-
Comparison of obinutuzumab and rituximab for treating primary membranous nephropathy Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-29 Xiaofan Hu, Muyin Zhang, Jing Xu, Chenni Gao, Xialian Yu, Xiao Li, Hong Ren, Weiming Wang, Jingyuan Xie
tration rate (eGFR) ≥30 mL/min/1.73 m2 despite six months of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker and treatment with obinutuzumab or rituximab were included and matched by propensity score (ratio: 1:2) based on age, sex, urine protein, eGFR, and titers of Anti-Phospholipase A2 receptor (PLA2R) antibody. The primary outcome was defined as a combination of partial or
-
The Association between Residential Segregation and Access to Kidney Transplantation: Evidence from a Multistate Cohort Study Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-26 Jasmine Berry, Aubriana Perez, Mengyu Di, Chengcheng Hu, Stephen O. Pastan, Rachel E. Patzer, Jessica L. Harding
hborhoods historically influenced by racial segregation have reduced access to health care. Whether this is true for individuals with ESKD seeking transplant is unknown. Methods We identified Black or White adults (N=42,401; 18–80 years) with ESKD initiating KRT in three US states (Georgia, North Carolina, South Carolina) between January 2015 and December 2019, with follow-up through 2020, from the
-
Urinary Response to Consuming Plant-Based Meat Alternatives in Persons with Normal Kidney Function: The SWAP-MEAT Pilot Trial Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-26 Catherine P. Ward, Matthew J. Landry, Kristen M. Cunanan, Kalani L. Raphael, Christopher C. Dant, Christopher D. Gardner, Alan C. Pao
Study findings suggest potential benefits of plant-based meat for patients with kidney disease. Background Consuming excess animal meat may exacerbate kidney disorders, such as urinary stone disease and CKD. Plant-based meat alternatives imitate animal meat and replace animal with vegetable protein, but it is unclear whether eating plant-meat confers similar health benefits as eating whole vegetables
-
Association of Kidney Function with Sodium-Glucose Co-Transporter 2 Inhibitor Discontinuation among US Veterans Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-21 Jesse C. Ikeme, Erin Madden, Julio A. Lamprea-Montealegre, Chi D. Chu, Michael G. Shlipak, Ian E. McCoy, Michelle M. Estrella
LT2i discontinuation in patients with CKD may limit the cardiokidney benefits of SGLT2i in real-world practice. Background The effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i) on cardiovascular disease and CKD may be limited if discontinued in persons with CKD. We sought to determine whether CKD at SGLT2i initiation was associated with subsequent discontinuation. Methods This cohort study
-
Cystatin C and Kidney Function Recovery in Patients Requiring Continuous KRT for Acute Kidney Injury Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-21 Sarah M. Haeger, Kayo Okamura, Amy S. Li, Zhibin He, Bryan D. Park, Isadore M. Budnick, North Foulon, Matthew Kennis, Rachel E. Blaine, Makoto Miyazaki, Ruth Campbell, Diana I. Jalal, James F. Colbert, John T. Brinton, Benjamin R. Griffin, Sarah Faubel
Background Plasma cystatin C is a reliable marker to estimate kidney function; however, it is unknown whether this remains true in patients receiving continuous KRT (CKRT). In this study, we tested the hypothesis that lower concentrations of plasma cystatin C during the first 3 days of CKRT would predict kidney function recovery. Methods We performed a retrospective observational study of 72 patients
-
Large Discordance between Creatinine-Based and Cystatin C–Based eGFRs is Associated with Falls, Hospitalizations, and Death in Older Adults Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-15 Nurit Katz-Agranov, Meghan L. Rieu-Werden, Ayush Thacker, Jacquelyn M. Lykken, Meghan E. Sise, Sachin J. Shah
ltiple ways to measure differences in creatinine and cystatin C; all produce similar associations with aging-related adverse outcomes. Background eGFR calculated using creatinine and cystatin C often differ in older adults. We hypothesized that older adults with cystatin C–based eGFR (eGFRcys) values significantly lower than creatinine-based eGFR (eGFRcr) values may have higher risk of aging-related
-
Association of Intake of Whole Grains with Health Outcomes in the Chronic Renal Insufficiency Cohort Study Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-14 Dillon Winkelman, Julie Smith-Gagen, Casey M. Rebholz, Orlando M. Gutierrez, David E. St-Jules
may be unwarranted. Background Patients with CKD are encouraged to choose refined grains instead of whole grains as part of the low-phosphorus diet for managing CKD-mineral and bone disorders (CKD-MBD). However, there is no direct evidence indicating that limiting whole grains has a beneficial impact on CKD outcomes. Methods This study analyzed Chronic Renal Insufficiency Cohort data in two ways, namely
-
Transforming Dialysis Access Together: A Multidisciplinary, Cross-Cutting, Patient-Centered Initiative Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-14 Vandana Dua Niyyar, Gerald A. Beathard, Gordon McLennan, Matthew A. Sparks, Kristina Bryant, Cynthia Delgado, Nichole Jefferson, Joseph Kessler, Kerry Leigh, Susan Stark, Prabir Roy-Chaudhury, Transforming Dialysis Access Together (TDAT)
An abstract is unavailable.
-
Automated Dialysis Anemia Management: Role of the Treating Nephrologist Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-13 Steven Fishbane, Hitesh H. Shah
An abstract is unavailable.
-
Biopsy-Based Transcriptomics May Be Precisely What Is Needed in Post-Kidney Transplant Care Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-13 David M. White
An abstract is unavailable.
-
Definition of Oliguria in the Intensive Care Unit: How Do You Do It? Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-09 Chloe G. Braun, Javier A. Neyra
An abstract is unavailable.
-
Physical Function and Mortality in Older Adults with Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-08 Christine K. Liu, Gomathy Parvathinathan, Margaret R. Stedman, Stephen L. Seliger, Daniel E. Weiner, Manjula Kurella Tamura, for the CRIC Study Investigators
y was pursued.When older adults with CKD and their families face treatment decisions, clinicians should utilize walking speed to frame discussions of prognosis. Background Accurate mortality prediction can guide clinical care for older adults with CKD. Yet existing tools do not incorporate physical function, an independent predictor of death in older adults. We determined whether incorporating physical
-
The Relevance of Phytate for the Treatment of Chronic Kidney Disease Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-07 Maryam Ekramzadeh, Kamyar Kalantar-Zadeh, Joel D. Kopple
ds, particularly in the seeds, nuts, grains, and fruits of plants. This article reviews the structure and many actions of phytate with particular reference to its potential effects on people with CKD. Phytate binds avidly to and can reduce gastrointestinal absorption of the phosphate anion and many macrominerals and trace elements including iron, zinc, calcium, and magnesium. This has led some opinion
-
Gender Differences in Citation Rate: An Analysis of Randomized Controlled Trials in Nephrology High-Impact Journals Over Two Decades Clin. J. Am. Soc. Nephrol. (IF 8.5) Pub Date : 2024-08-06 Qandeel H. Soomro, Shuojohn Li, Angela McCarthy, Dalila Varela, Javaughn Ways, Amalya M. Charytan, Colin Keane, Giana Ramos, Joey Nicholson, David M. Charytan
ckground Historically, women's scientific contributions have been under-recognized. We investigated whether the number of citations, a key metric used for academic promotions and scientific productivity, differs in nephrology high-impact publications on the basis of author's gender. Methods We identified randomized clinical trials from 2000 to 2021 in ten high-impact journals. We assessed author gender